Zobrazeno 1 - 6
of 6
pro vyhledávání: '"C B, Pelissari"'
Autor:
J. B. de Alencar, Andressa Higa Shinzato, José Machado, Ana Maria Sell, Jeane Eliete Laguila Visentainer, M. F. de Barros, Camila Rodrigues, Luciana Conci Macedo, C. B. Pelissari
Publikováno v:
Haemophilia. 21:e312-e316
The development of factor VIII (FVIII) inhibitor is the main complication of replacement therapy in patients with haemophilia A (HA). A ratio of 5-7% of individuals HA develops antibodies (inhibitors) against the FVIII infused during the treatment, t
Autor:
Marco Antônio Braga, F. C. de Melo, L. De Souza Hirle, Ana Maria Sell, M. F. de Barros, Juliana Curi Martinichen Herrero, José Machado, S. De Souza Schiller, Jeane Eliete Laguila Visentainer, C. B. Pelissari
Publikováno v:
Haemophilia. 18:e236-e240
Congenital haemophilia A is a chromosome-linked recessive disorder caused by the deficiency or reduction of factor VIII (FVIII) pro-coagulant activity. During treatment, some patients develop alloantibodies (FVIII inhibitors) that neutralize the acti
Autor:
C. B. Pelissari, Orlando César de Oliveira Barretto, Aguinaldo José do Nascimento, Kimiyo Nonoyama, Maria Sueli Soares Leonart
Publikováno v:
São Paulo Medical Journal, Vol 118, Iss 2, Pp 41-45 (2000)
Sao Paulo Medical Journal, Volume: 118, Issue: 2, Pages: 41-45, Published: 02 MAR 2000
Sao Paulo Medical Journal v.118 n.2 2000
São Paulo medical journal
Associação Paulista de Medicina
instacron:APM
Sao Paulo Medical Journal, Volume: 118, Issue: 2, Pages: 41-45, Published: 02 MAR 2000
Sao Paulo Medical Journal v.118 n.2 2000
São Paulo medical journal
Associação Paulista de Medicina
instacron:APM
CONTEXT: The preservative solution ADSOL (adenine, dextrose, sorbitol, sodium chloride and mannitol) maintains red cell viability for blood trans-fusion for 6 weeks. It would be useful to know about its preservation qualities over longer periods. OBJ
Autor:
M F, De Barros, J C M, Herrero, A M, Sell, F C, De Melo, M A, Braga, C B, Pelissari, J, Machado, S, De Souza Schiller, L, De Souza Hirle, J E L, Visentainer
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 18(3)
Congenital haemophilia A is a chromosome-linked recessive disorder caused by the deficiency or reduction of factor VIII (FVIII) pro-coagulant activity. During treatment, some patients develop alloantibodies (FVIII inhibitors) that neutralize the acti
Autor:
Aquinaldo J. Nascimento, Geraldo Picheth, C. B. Pelissari, Maria Suely Soares Leonart, Debora Regina Daga, Fábio O. Pedrosa, Emanuel Maltempi de Souza, I. C. R. Santos
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 408(1-2)
Autor:
C. B. Pelissari, K. Nonoyama, Aguinaldo José do Nascimento, O.C. de O. Barretto, A. E. M. Stinghen, Maria Suely Soares Leonart
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 30, Iss 6, Pp 745-747 (1997)
Brazilian Journal of Medical and Biological Research, Vol 30, Iss 6, p 745 (1997)
Brazilian Journal of Medical and Biological Research, Vol 30, Iss 6, p 745 (1997)
Red blood cells (RBC) are viable if kept in an adequate preservative solution, although gradual changes in morphology and metabolism may occur. There is a gradual decrease in adenosine-5'-triphosphate (ATP) concentration, pH, glucose consumption, and